5th Circ. Affirms Brand, Generic Wins In Reglan Suits

Law360, New York (February 21, 2014, 7:02 PM EST) -- The Fifth Circuit on Friday upheld victories for brand-name and generic makers of the heartburn drug Reglan in two personal injury lawsuits, rejecting the plaintiffs' assertion that their claims against the generic makers are not preempted because they parallel federal law.

In a nonprecedential opinion, the appeals court affirmed the dismissal of claims against generic manufacturers Watson Pharma Inc., Watson Laboratories Inc., Teva Pharmaceuticals USA Inc., Pliva Inc. and Vintage Pharmaceuticals LLC and the granting of summary judgment in favor of Pfizer Inc., Wyeth Inc. and...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Walter Lashley v. Pfizer, Incorporated, et al


Case Number

12-60861

Court

Appellate - 5th Circuit

Nature of Suit

4365 P.I. - Product Liability

Date Filed

November 4, 2012


Case Title

Maria Del Valle v. Pliva, Inc., et al


Case Number

12-41148

Court

Appellate - 5th Circuit

Nature of Suit

4365 P.I. - Product Liability

Date Filed

October 15, 2012

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.